lung injury Upgrades to CareDx's AlloSure Test Enable Earlier Detection of Transplant Rejection Premium AlloSure 3.0 can diagnose the very early stages of T-cell mediated rejection, allowing clinicians to begin anti-rejection therapies and monitor treatment. CareDx Expands AlloSure Transplant Test to Lung, Starting With Compassionate Use Premium The company is currently conducting clinical studies to validate AlloSure's technology — which underlies its kidney transplant test — in lung transplant patients. Liquid Biopsy Dx Looks for Donor-Derived DNA as Measure of Chronic Lung Transplant Rejection Premium A team led by researchers at the NHLBI are testing the efficacy of measuring ddcfDNA in blood as a biomarker of chronic rejection for lung transplants. Silence Puts Sepsis Program on Backburner as it Advances Cancer Drug Premium NEW YORK (GenomeWeb) – Silence Therapeutics this month disclosed that it was ending its work with investigational sepsis drug Atu112 amid disappointing results in preclinical testing. Silence Plans $28.6M Stock Sale to Fund Expansion of Staff, Pipeline Premium Silence Therapeutics this week announced that it is closing in on a much-needed financial shot in the arm, inking deals to raise £18.7 million ($28.6 million) through the private placement of 9.5 million shares to certain investors. Sep 13, 2012 Silence Says Lung Injury Drug Shows Promise in Animal Study Premium Mar 22, 2012 Silence Says Cash Runway Ends in Q3, Directors Have 'Uncertainty' About Additional Fundraising Premium Feb 16, 2012 With New CEO, Silence Looks to Find Partners and Advance a New Drug into the Clinic Premium Jun 2, 2011 Silence Raises Nearly $10M, Provides Timeline for Pipeline Programs Premium Feb 4, 2009 23andMe, MondoBiotech Collaborate to Study Genetic Risk for Rare Diseases Premium Breaking News Analysis Finds Sibling Cascade Testing Could Be Cost Effective in Pediatric Cancer Armonica Technologies Closes $2M Series B Financing Round Top Five Articles on GenomeWeb Last Week: SARS-CoV-2 PCR Tests; California Cancer Testing Law; More In Brief This Week: The Jackson Laboratory, CareDx, Merck Global Health Innovation Fund, and More People in the News: New Appointments at Grail, Foundation Medicine, Personalis, More New Products Posted to GenomeWeb: NanoString, Sophia Genetics, EliTech, Lybe Scientific, More The Scan J&J Booster Support A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times. To Keep the Cases Moving The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases. NAS Expels Archaeologist Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences. PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.